Paper: Real-World Utilization of Fedratinib for Myelofibrosis Post-Ruxolitinib: Patient Characteristics, Treatment Patterns, and Characterization of Ruxolitinib Failure

Real-world Utilization of Fedratinib for Myelofibrosis Post-Ruxolitinib

Read the full article here

Related Articles